TPE in Heparin-Induced Thrombocytopenia (HIT) - Clinical Trial

What is the Purpose of this Study?

We are doing this study is to understand how TPE (therapeutic plasma exchange) can help to decrease blood-clotting risk in patients.

What is the Condition Being Studied?

Heparin-induced thrombocytopenia (HIT)

Who Can Participate in the Study?

Adult ages 18+ who are receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH).

Age Group

What is Involved?

If you choose to join this study, you will:

  • Participate in the study for about 30 days
  • Provide blood samples throughout the study

Study Details

Full Title
Defining the Role of Therapeutic Plasma Exchange in Heparin Induced Thrombocytopenia
Principal Investigator
Protocol Number
IRB: PRO00086436
Enrollment Status
Open for Enrollment